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January 2013296 AbstractsExtracorporeal Bypass Use Improves Outcomes of Open Thoracic and
Thoracoabdominal Aneurysm Repair
Virendra I. Patel, MD, MPH, Shankha Mukhopadhyay, MS, Emel Ergul,
MS, Mark F. Conrad, MDMSSc, Richard P. Cambria, MD. Massachusetts
General Hospital, Boston, Mass
Objectives: There is no consensus on the use or benefit of extracorpo-
real circulation (EC) during descending thoracic (DTA) or thoracoabdomi-
nal aneurysm (TAA) repair. We evaluated the role of EC during DTA or
TAA repair using U.S. Medicare data.
Methods: Medicare (2004-2007) patients undergoing intact open
DTA or TAA repair were identified by ICD-9 code; specific exclusions
included ascending/arch and hypothermic circulatory arrest (DHCA) op-
erations. The impact of EC (ICD-9 39.61) on early and late outcomes was
analyzed using standard statistical methods.
Results: A total of 4230 patients had DTA or TAA repair, with EC
used in 2433 (57%). Differences in baseline clinical features are presented
in the Table. The 30-day mortality, any complication, and systemic
complications were significantly reduced with EC use (Table). EC pa-
tients had shorter length of stay of 13.5 13 vs 17.2 18 days (P .01)
and lower total hospital charges of $151,000 $140,000 vs $180,000
$190,000 (P .01). EC patients were more likely to be discharged home
than to an extended care facility (67% vs 56%; P  .01). Multivariable
regression modeling (odds ratio [95% confidence interval] to adjust for
baseline clinical differences showed EC to independently reduce opera-
tive mortality (0.80 [0.65-0.97]; P  .02), any complication (0.67
[0.59-0.76]; P  .01), pulmonary complications (0.68 [0.59-0.79]; P 
.01), and acute renal failure (0.52; [0.44-0.61]; P  .01). Long-term
survival was higher (log-rank P  .01) in EC patients at 1 year (81% 
0.8% vs 73%  1%) and 5 years (67%  1% vs 52%  1%). Risk-adjusted
Cox proportional hazards regression also showed that EC was indepen-
dently associated with improved long-term survival (odds ratio, 0.69;
95% confidence interval, 0.63-0.74; P  .01).
Conclusions:Although important clinical variables such as DTA/TAA
extent and spinal cord ischemic complications cannot be assessed with the
Medicare database, EC used during open DTA and TAA repair significantly
reduces operative mortality, morbidity, and procedural costs, and improves
late survival. These data indicate EC should be amore widely applied adjunct
in DTA/TAA open surgery.
Table. Univariate differences in clinical features and outcomes after DTA/TAA
repair
Variable Extracorporeal bypass No bypass (clamp/sew) P
(n  2433) (n  1797)
Clinical features
Age, years 73  7.6 71.7  8 .01
Female sex 52% 48% .01
CAD 23% 24% .7
COPD 28% 34% .01
PVD 5.7% 11.3% .01
CKD 5.5% 7.7% .01
Outcomes
30-day mortality 9.7% 12.2% .01
Complications
Any 49% 58% .01
Cardiac 14% 13% .16
Pulmonary 21% 27% .01
Acute renal failure 14% 24% .01
Bleeding 13% 19% .01
Infectious 5.9% 7.7% .01
CAD, Coronary artery disease; CKD, chronic kidney disease; COPD, chronic
obstructive pulmonary disease; PVD, peripheral vascular disease.
Iliac Artery Exposure Independently Predicts Mortality in Female
Patients Undergoing Thoracic Endovascular Aortic Aneurysm Repair
(TEVAR): An Analysis of the ACS-NSQIP Database
George J. Arnaoutakis, MD, James H. Black, III, MD, Eric B. Schneider,
PhD, Ying W. Lum, MD, Mahmoud B. Malas, MD, Bruce A. Perler, MD,
MBA, Julie A. Freischlag, MD, Christopher J. Abularrage, MD. The Johns
Hopkins Hospital, Baltimore, Md
Objectives: Previous studies have shown that female gender is
associated with increased morbidity and mortality after endovascular
abdominal aortic aneurysm repair. The goal of this study was to assess the
effect of gender on the 30-day outcomes of thoracic endovascular aortic oneurysm repair (TEVAR) using the American College of Surgeons-
ational Surgical Quality Improvement Program (ACS-NSQIP) data-
ase.
Methods: This was a review of the 2005 to 2010 ACS-NSQIP
atabase to identify all patients who underwent TEVAR for nonruptured
horacic aortic aneurysm. Procedure and diagnosis codes were used to
apture the study population. Patients were stratified according to gen-
er. Baseline, operative, and outcomes data were compared in bivariate
ashion. The 30-day mortality was the primary outcome measure, and a
ultivariable logistic regression model was used to identify independent
ssociations.
Results: During the study period, 649 patients, comprising 279
omen (43%) and 370 men (57%), underwent TEVAR. Baseline demo-
raphics according to gender were similar; however, women were less
ikely to drink alcohol (1% vs 5%; P  .001) and to have a history of
ardiac surgery (14% vs 27%; P  .001). More women required iliac
rtery exposure (18% vs 7%; P  .001). Women had increased operative
imes (173.6  6.3 vs 159.8  5.2 minutes; P  .03), transfusion rates
30% vs 17%, P  .001), and hospital length of stay (7.7  0.5 vs 7.6 
.5 days; P  .009) compared with men. Overall postoperative compli-
ations were similar, but unadjusted mortality was significantly greater in
omen (6% vs 3%; P  .03). On multivariable analysis (odds ratio [95%
onfidence interval], female gender was no longer a significant predictor
f mortality (2.30 [0.99-5.34]; P .053), but independent predictors of
0-day mortality included increasing age (1.05 [1.01-1.09]; P  .02),
mergency procedure (3.76 [1.79-7.87]; P  .001), and iliac artery
xposure (4.42 [2.07-9.44]; P  .001).
Conclusions: The 30-day mortality is increased in women compared
ith men. This seems to be explained by an increased need for iliac artery
xposure that results in increased operative times, transfusion rates, and
0-day mortality after TEVAR for unruptured thoracic aortic aneurysms.
hese findings represent a strong need for decreased device delivery size
nd improvements in endovascular technology.
utcomes of Lower Extremity Bypass Performed for Acute Limb
schemia
onald T. Baril, MD,1 Virendra I. Patel, MD,2 Dejah R. Judelson, MD,1
hilip P. Goodney, MD,3 James T. McPhee, MD,4 Scott G. Prushik, MD,5
athanael Hevelone, MPH,6 Jack L. Cronenwett, MD,3 Andres Schanzer,
D1. 1University of Massachusetts Medical Center, Worcester, Mass;
Massachusetts General Hospital, Boston, Mass; 3Dartmouth-Hitchcock
edical Center, Lebanon, NH; 4BostonMedical Center, Boston,Mass; 5St.
lizabeth’s Medical Center, Boston, Mass; 6Harvard School of Public
ealth, Boston, Mass
Objectives: Acute limb ischemia (ALI) remains one of the most
hallenging emergencies in vascular surgery. Historically, outcomes after
nterventions for ALI have been associated with high rates of morbidity and
ortality. The purpose of this study was to determine contemporary out-
omes after lower extremity bypass (LEB) performed for ALI.
Methods: All patients undergoing infrainguinal LEB between 2003
nd 2011 within hospitals comprising the Vascular Study Group of New
ngland (VSGNE) were identified. Patients were stratified according to
hether the indication for LEBwas ALI. Primary end points included bypass
raft occlusion, major amputation, and mortality at 1 year postoperatively as
etermined by Kaplan-Meier life-table analyses. Multivariable Cox propor-
ional hazards models were constructed to evaluate independent predictors
f mortality and major amputation at 1 year.
Results: Of 5712 LEB procedures, 323 (5.7%) were performed for
LI. Patients undergoing LEB for ALI were similar in age (66 vs 67
ears; P  .084) and gender (68% male vs 69% female; P  .617), but
ere less likely to be taking aspirin (63% vs 75%, P  .0001) or a statin
55% vs 68%; P  .0001). Patients with ALI were more likely to be
urrent smokers (49% vs 39%; P  .0001), and to have had a prior
psilateral bypass (33% vs 24%; P  .004) or a prior ipsilateral percutane-
us intervention (41% vs 29%, P  .001). Bypasses performed for ALI
ere longer in duration (270 vs 244 minutes; P  .0001), had greater
lood loss (363 vs 272 mL; P  .0001), and more commonly used
rosthetic conduits (41% vs 33%; P  .003). ALI patients experienced
ncreased in-hospital major adverse events, including myocardial infarc-
ion, congestive heart failure, deterioration in renal function, and respi-
atory complications (Table). Patients who underwent LEB for ALI had
o difference in rates of graft occlusion, but did have significantly higher
ates of limb loss and mortality at 1 year (Table). On multivariate analysis,
LI was an independent predictor of major amputation (HR, 2.16; CI,
.38-3.40; P .001) and mortality (HR, 1.41; CI, 1.09-1.83; P .009)
t 1 year.Conclusions: Patients who present with ALI represent a less medically
ptimized subgroup within the population of patients undergoing LEB.
